Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy

| August 16, 2014 | 0 Comments

Azizi July August 2014by Abbas Mirshafiey; Ghasem Ghalamfarsa; Babak Asghari; and Gholamreza Azizi
Dr. Mirshafiey is from the Departmant of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Dr. Ghalamfarsa is from Cellular & Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, Iran; Dr. Asghari is from Antimicrobial Resistance Research Center, Faculty of Medicine, Iran University of Medical Science, Tehran, Iran; Dr. Azizi is from Imam Hassan Mojtaba Hospital, Alborz University of Medical Sciences, Karaj, Iran.

Innov Clin Neurosci. 2014;11(7–8):23–36

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , ,

Category: Drug Development, Multiple Sclerosis, Neurology, Past Articles, Review

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.